Singularity Maker

Where the biotech, startup and investment community gather to discuss issues that affect APAC's entrepreneurial ecosystem.

[Singularity Maker @SingularityMak2]

#cool #technologytrends

CES 2020 Best of Innovation award ｜ New Sleep Number Climate360™ smart bed

@sleepnumber 😊

https://t.co/lozNvsarIZ

[Singularity Maker @SingularityMak2]

@WeAreKindbody has raised another $4.5M USD from @googleventures . For more infertility test, or egg freezing, you can go check it.

https://t.co/4YAEhG91p6

[Singularity Maker @SingularityMak2]

No more nightmare!
No more #insomnia !

Remrise comes up with a sleep solution via the Chinese medicine.

I can guarantee no monkey brain or donkey skin!
https://t.co/xgPGZ5sUbd

[Singularity Maker @SingularityMak2]

China Medbanks has annouced the completion of RMB $1 billion series D+ funding round from #Tecent, and joined by the investors from the previous round, including Wu Capital, F-Prime Capital, CICC, and IDG Capital.

https://t.co/5Y9KRKhoZT

[Singularity Maker @SingularityMak2]

@wellingtonvc & @NovoVentures Build a new biotech fund focusing on Europe area.

For those #biotechnology startups who are interested in finding the financial support, you may wanna check out the scale and how to apply.

https://t.co/xjg0Dq7Hlt

[Singularity Maker @SingularityMak2]

Female-only #cannabis beverage from
@Kikoko_hq

▶▶ HoneyShot

I bet ya'll wanna try.😋😋

https://t.co/JjHhuuP6iP

[Singularity Maker @SingularityMak2]

Chinese Amazon~ Singles' Day makes another legend in 2019!!! 💯

https://t.co/32vcnTjvHU

[Singularity Maker @SingularityMak2]

China based chain #ophthalmology service provider, Purui Bright Eye Hospital has welcomed RMB $200 million investment from China Life Big Health Fund.

https://t.co/d3JP16Utkg

[Singularity Maker @SingularityMak2]

A US-based at home #workout #startup , Katalyst Fitness, has raised $5.6 million USD in series A funding from @OctopusVentures .

you may not need to hit the gym and get a perfect figure.
💗Electrical muscle stimulation (#EMS ) is ya second choice.

https://t.co/1aEtPPCSIH

[Singularity Maker @SingularityMak2]

Stone Capital has partnered with the #Singapore #Biosyngen Group to build a US $50 million investment fund in Singapore with a primary focus on biopharmaceuticals.

https://t.co/CdEOTYLn47

[Singularity Maker @SingularityMak2]

@AiCureMed's platform works to capture the facial expressions and physiological data of patients during the medication through the lens of a tablet or mobile phone, and then analyze it with the #AI system.
https://t.co/y7aNkI6kKD

[Singularity Maker @SingularityMak2]

@putibaby, a ＃maternal and ＃child service platform, received a round of financing from Silicon Valley venture capitalist Wufu Chen for millions RMB, and reached a strategic cooperation with Tasteforlife, a female post-natal conditioning food company.
https://t.co/l824BRKzd6

[Singularity Maker @SingularityMak2]

A new therapy for #diabetic Patients with #optogenetic regulation of #pancreatic beta cells.
https://t.co/jZicy82qvR

[NYT Health @NYTHealth]

Are medical scientists at American institutions sending research findings to China? Scores of universities have begun investigations, but critics say ethnically Chinese academics are being singled out without reason. https://t.co/1F2AdymMD4

[Singularity Maker @SingularityMak2]

💉Helicobacter pylori,
nearly half of the world's populations has suffered from.

Singularity Maker has discovered a new drug treatment for this disease. With less drug resistance!!

https://t.co/nkV2c9IvTJ

[Singularity Maker @SingularityMak2]

Center Ventures’s Subsidiary TOT Biopharma Successfully Listed In HKEX!

Click the following link, you'll find the stock price and more details.

https://t.co/FFVeTPEm6v

[Singularity Maker @SingularityMak2]

@Path_AI, a United States based, announced that it has received a strategic investment from @bmsnews (BMS) and the @Merck Global Health Innovation Fund (Merck GHIF).
https://t.co/y0n1WTlwZ3

[Singularity Maker @SingularityMak2]

@Path_AI, a United States based, announced that it has received a strategic investment from @bmsnews (BMS) and the @Merck Global Health Innovation Fund (Merck GHIF).
https://t.co/y0n1WTlwZ3

[Singularity Maker @SingularityMak2]

@TakedaPharma spends €130Mi to set up a factory to produce #dengue #vaccine in #Germany. It is expected to recruit 200 full-time employees and give priority to the application for approval in the dengue #epidemic area.
https://t.co/CUed0b6Ds9

[Singularity Maker @SingularityMak2]

@TakedaPharma spends €130Mi to set up a factory to produce #dengue #vaccine in #Germany. It is expected to recruit 200 full-time employees and give priority to the application for approval in the dengue #epidemic area.
https://t.co/CUed0b6Ds9